Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Project title: NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) for the treatment of HIV (Lot 1) & For the provision of a service to supply over labelled Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) Packs for the prevention of HIV (Lot 2) 1st November 2024
Offer reference number: CM/PHS/24/5709
Period of framework agreement: 1st November 2024 to 31st October 2026 with an option to extend (at the Authority's discretion) for a further period (or periods) up to a total of 24 months.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Abbvie Ltd | 08004972 | ~£626,522,476 estimated from lot values | LOBBYIST Policy Connect Limited (15 quarters) WA Communications Ltd (3 quarters) Portland PR Limited (3 quarters) Incisive Health Ltd (1 quarter) Political Lobbying & Media Relations Limited (1 quarter) |
| Amarox Limited | 10997632 | ~£626,522,476 estimated from lot values | - |
| Dr.Reddy's Laboratories (UK) Limited | 01729064 | ~£626,522,476 estimated from lot values | - |
| Gilead Sciences Limited | 02543818 | ~£626,522,476 estimated from lot values | LOBBYIST Ovid Consulting Ltd (4 quarters) Portland PR Limited (1 quarter) WA Communications Ltd (1 quarter) |
| Janssen-Cilag Ltd | 01027904 | ~£626,522,476 estimated from lot values | LOBBYIST Ovid Consulting Ltd (4 quarters) |
| Lupin Healthcare (UK) Limited | 06925119 | ~£626,522,476 estimated from lot values | - |
| Macleods Pharma UK Limited | 06455382 | ~£626,522,476 estimated from lot values | - |
| Mawdsley-Brooks & Co Ltd | 00044701 | ~£626,522,476 estimated from lot values | - |
| Merck Sharpe & Dohme (UK) Limited | - | ~£626,522,476 estimated from lot values | - |
| Milpharm Ltd/aurobinbdo Primary | - | ~£626,522,476 estimated from lot values | - |
| MSN Laboratories Europe Limited | 10185013 | ~£626,522,476 estimated from lot values | - |
| Mylan | 05460854 | ~£626,522,476 estimated from lot values | - |
| ViiV Healthcare UK Ltd | 06990358 | ~£626,522,476 estimated from lot values | - |
Government spending data: These suppliers have received £227,760,001 in 2,402 payments (over £25k) from Department of Health and Social Care, Manchester University NHS Foundation Trust, The Christie NHS Foundation Trust, NHS England, Guy's and St Thomas' NHS FT and 17 more public bodies (2018-06-22 to 2026-03-31).